Chapter 2

The Surveillance and Burden of Chronic Kidney Disease

Chaisiri Angkurawaranon

Chaisiri Angkurawaranon

Department of Family Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Search for more papers by this author
Dorothea Nitsch

Dorothea Nitsch

Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom

Search for more papers by this author
Ben Caplin

Ben Caplin

Department of Renal Medicine, University College London, London, United Kingdom

Search for more papers by this author
First published: 18 November 2022

Summary

In terms of chronic kidney disease (CKD), surveillance refers to activities aimed at providing key information on the burden of, and risk factors for, CKD with a view to reducing variation in, and improving the quality of, care processes and health outcomes associated with the condition. Surveillance systems are generally divided into passive and active approaches. Any form of CKD surveillance should provide meaningful data as to whether burden of disease is increasing, decreasing, or stable in a population and many outputs can also be used to detect differences between populations. With all approaches based on the testing of renal biomarkers, it is also important to consider the issues surrounding laboratory calibration and external quality assurance which can be the source of substantial measurement error. Population-based surveys provide the gold-standard for assessing the prevalence of CKD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.